(Q39885205)

15 September 2017

title

A novel mechanism for anti-EGFR antibody action involves chemokine-mediated leukocyte infiltration (English)

1 reference

15 September 2017

1 reference

Enikö Sonkoly

3

0 references

Andor Pivarcsi

object named as

Andor Pivarcsi

6

0 references

Sven Brandau

object named as

Sven Brandau

4

0 references

author name string

Thomas K Hoffmann

1

1 reference

15 September 2017

Kerstin Schirlau

2

1 reference

15 September 2017

Stephan Lang

5

1 reference

15 September 2017

Vera Balz

7

1 reference

15 September 2017

Anja Müller

8

1 reference

15 September 2017

Bernhard Homey

9

1 reference

15 September 2017

Edwin Boelke

10

1 reference

15 September 2017

Torsten Reichert

11

1 reference

15 September 2017

Ulrike Friebe-Hoffmann

12

1 reference

15 September 2017

Jens Greve

13

1 reference

15 September 2017

Patrick Schuler

14

1 reference

15 September 2017

Kathrin Scheckenbach

15

1 reference

15 September 2017

Jörg Schipper

16

1 reference

15 September 2017

Murat Bas

17

1 reference

15 September 2017

Theresa L Whiteside

18

1 reference

15 September 2017

Henning Bier

19

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 June 2009

1 reference

International Journal of Cancer

15 September 2017

published in

1 reference

15 September 2017

volume

124

1 reference

15 September 2017

issue

11

1 reference

15 September 2017

page(s)

2589-2596

1 reference

Autocrine secretion and malignant transformation of cells.

15 September 2017

cites work

1 reference

Over-expression of the EGF receptor is a hallmark of squamous cell carcinomas

21 January 2018

1 reference

Epidermal growth factor-related peptides and their receptors in human malignancies

21 January 2018

1 reference

Molecular targets in cancer therapy and their impact on cancer management

21 January 2018

1 reference

Multiple positive and negative regulators of signaling by the EGF-receptor

21 January 2018

1 reference

Signal transduction by receptors with tyrosine kinase activity

21 January 2018

1 reference

The epidermal growth factor receptor and its inhibition in cancer therapy

21 January 2018

1 reference

Epidermal growth factor receptor family tyrosine kinases as signal integrators and therapeutic targets

21 January 2018

1 reference

Epidermal growth factor receptor targeting in cancer

21 January 2018

1 reference

Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents

21 January 2018

1 reference

Molecular therapy of head and neck cancer.

21 January 2018

1 reference

Anti-(epidermal growth factor) receptor monoclonal antibodies for the induction of antibody-dependent cell-mediated cytotoxicity against squamous cell carcinoma lines of the head and neck

21 January 2018

1 reference

Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide

21 January 2018

1 reference

Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor

21 January 2018

1 reference

Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer

21 January 2018

1 reference

A specific inhibitor of the epidermal growth factor receptor tyrosine kinase

21 January 2018

1 reference

Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC)

21 January 2018

1 reference

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

Chemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapy

21 January 2018

1 reference

Monocyte chemotactic proteins from human tumor cells

21 January 2018

1 reference

Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes

21 January 2018

1 reference

Targeting epidermal growth factor receptor in head and neck cancer

21 January 2018

1 reference

Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody

21 January 2018

1 reference

Clinical implications of the mechanism of epidermal growth factor receptor inhibitors

21 January 2018

1 reference

Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx

21 January 2018

1 reference

Developments in epidermal growth factor receptor-targeting therapy for solid tumors: focus on matuzumab (EMD 72000).

21 January 2018

1 reference

The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468.

21 January 2018

1 reference

Immune activation by epidermal growth factor receptor specific monoclonal antibody therapy for head and neck cancer

21 January 2018

1 reference

Immunobiology of head and neck cancer

21 January 2018

1 reference

Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation

21 January 2018

1 reference

The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells

21 January 2018

1 reference

Tumor immune escape by the loss of homeostatic chemokine expression.

21 January 2018

1 reference

Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer.

21 January 2018

1 reference

The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor

21 January 2018

1 reference

Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment

21 January 2018

1 reference

CCL2 (monocyte chemoattractant protein-1) and cancer

21 January 2018

1 reference

Induction of natural killer cell migration by monocyte chemotactic protein−1, −2 and −3

21 January 2018

1 reference

Stable cell membrane labelling

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.24269

1 reference

release_24we7yhk5nbezefbcrm4gyil6m

15 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/24we7yhk5nbezefbcrm4gyil6m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference